Jaguar Health (JAGX) Enterprise Value (2014 - 2026)
Jaguar Health (JAGX) reported Enterprise Value of -$11.6 million for Q1 2026, down 75.22% year-over-year from -$47.0 million in Q1 2025, and down 332.8% quarter-over-quarter from -$2.7 million in Q4 2025.
Jaguar Health (JAGX) Enterprise Value (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Enterprise Value data on file, last reported at -$11.6 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$11.6 million, down 75.22% year-over-year; the trailing twelve-month figure through Mar 2026 was -$11.6 million (down 75.22% YoY), and the FY2025 annual result was -$2.7 million, up 69.42% from the prior year.
- Enterprise Value fell to -$11.6 million in Q1 2026 per JAGX's latest filing, from -$2.7 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$2.7 million in Q4 2025 and troughed at -$17.4 million in Q1 2022.
- A 5-year average of -$9.1 million and a median of -$8.8 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value plunged 334.79% in 2024, then surged 79.76% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$5.2 million in 2022, then slipped by 24.99% to -$6.5 million in 2023, then plunged by 34.59% to -$8.8 million in 2024, then soared by 69.42% to -$2.7 million in 2025, then slumped by 332.8% to -$11.6 million in 2026.
- Business Quant data shows JAGX's Enterprise Value at -$11.6 million in Q1 2026, -$2.7 million in Q4 2025, and -$4.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -584.73 Mn |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | -11.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.64 Mn |
| Dec 31, 2025 | -2.69 Mn |
| Sep 30, 2025 | -4.80 Mn |
| Jun 30, 2025 | -3.32 Mn |
| Mar 31, 2025 | -6.64 Mn |
| Dec 31, 2024 | -8.79 Mn |
| Sep 30, 2024 | -13.78 Mn |
| Jun 30, 2024 | -16.38 Mn |
| Mar 31, 2024 | -11.85 Mn |
| Dec 31, 2023 | -6.53 Mn |
| Sep 30, 2023 | -3.17 Mn |
| Jun 30, 2023 | -8.44 Mn |
| Mar 31, 2023 | -14.06 Mn |
| Dec 31, 2022 | -5.23 Mn |
| Sep 30, 2022 | -10.61 Mn |
| Jun 30, 2022 | -8.97 Mn |
| Mar 31, 2022 | -17.39 Mn |
| Dec 31, 2021 | -16.81 Mn |
| Sep 30, 2021 | -12.38 Mn |
| Jun 30, 2021 | -9.92 Mn |